5 Latest Stock Picks of Chinese Billionaire Chen Tianqiao’s Shanda Asset Management

4. Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)

Shanda Asset Management’s Stake Value: $3.5 million

Percentage of Shanda Asset Management’s 13F Portfolio: 0.36%

Number of Hedge Fund Holders: 25

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) is an American pharmaceutical company whose products cover several diseases such as viral infections from the dengue virus and hepatitis C. It is also developing a treatment for the COVID-19 coronavirus.

As Q3 2021 came to an end, Mr. Chen’s Shanda Asset Management bought 100,000 Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)  shares. These were worth $3.5 million and represented 0.36% of its portfolio. During the same time period, 25 of the 867 hedge funds polled by Insider Monkey owned a stake in the pharmaceutical company.

Peter Kolchinsky’s RA Capital Management is Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)’s largest investor through a $190 million stake via 5.4 million shares.